scholarly article | Q13442814 |
P2093 | author name string | R. W. Olsen | |
T. M. DeLorey | |||
M. H. Brilliant | |||
C. Ferguson | |||
N. Hagiwara | |||
R. Mäkelä | |||
N. L. Harrison | |||
K. Snyder | |||
E. R. Korpi | |||
J. J. Quinlan | |||
A. Handforth | |||
M. D. Krasowski | |||
C. E. Rick | |||
G. E. Homanics | |||
L. L. Firestone | |||
P2860 | cites work | Teratogenicity of oral diazepam and diphenylhydantoin in mice | Q66938310 |
Cortical myoclonus in Angelman syndrome | Q71209362 | ||
Modulation of GABAA receptor tert-[35S]butylbicyclophosphorothionate binding by antagonists: relationship to patterns of subunit expression | Q71464636 | ||
Distribution, prevalence, and drug binding profile of gamma-aminobutyric acid type A receptor subtypes differing in the beta-subunit variant | Q72724862 | ||
Central inhibitory action attributable to presynaptic depolarization produced by muscle afferent volleys | Q79381316 | ||
Localization of the gene encoding the GABAA receptor beta 3 subunit to the Angelman/Prader-Willi region of human chromosome 15 | Q24678294 | ||
The γ-aminobutyric acid receptor γ3 subunit gene (GABRG3) is tightly linked to the α5 subunit gene (GABRA5) on human chromosome 15q11–q13 and is transcribed in the same orientation | Q28292627 | ||
TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD | Q28332332 | ||
Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology. | Q33902225 | ||
Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation | Q34301293 | ||
The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit | Q34341226 | ||
Phenotypic consequences of deletion of the gamma 3, alpha 5, or beta 3 subunit of the type A gamma-aminobutyric acid receptor in mice | Q35136430 | ||
Mapping the cleft-lip genes: the first fix? | Q35197363 | ||
Concordance between isolated cleft palate in mice and alterations within a region including the gene encoding the beta 3 subunit of the type A gamma-aminobutyric acid receptor | Q36337468 | ||
Genetic and molecular analysis of recessive alleles at the pink-eyed dilution (p) locus of the mouse | Q37129804 | ||
Benzodiazepine-induced motor impairment linked to point mutation in cerebellar GABAA receptor. | Q38322303 | ||
The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon | Q38330309 | ||
The GABAA receptors | Q40465950 | ||
Which GABAA-receptor subtypes really occur in the brain? | Q41003268 | ||
Role of neurotransmitters in palate development and teratologic implications | Q41339517 | ||
Deficiency of the beta 3 subunit of the type A gamma-aminobutyric acid receptor causes cleft palate in mice. | Q41671223 | ||
Retinoic acid-induced alterations in the expression of growth factors in embryonic mouse palatal shelves. | Q42477500 | ||
Face facts: genes, environment, and clefts. | Q42950785 | ||
Familial Angelman syndrome caused by imprinted submicroscopic deletion encompassing GABAA receptor beta 3-subunit gene | Q44615145 | ||
The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development | Q44767968 | ||
GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system | Q46188097 | ||
Pharmacological subtypes of the gamma-aminobutyric acidA receptors defined by a gamma-aminobutyric acid analogue 4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridin-3-ol and allosteric coupling: characterization using subunit-specific antibodies | Q46422577 | ||
Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors | Q48125834 | ||
A cluster of three GABAA receptor subunit genes is deleted in a neurological mutant of the mouse p locus. | Q48246711 | ||
Ligand-dependent effects of ethanol and diethylether at brain benzodiazepine receptors | Q48453006 | ||
Heterogeneity in EC50 and nH of GABAA receptors on dorsal root ganglion neurons freshly isolated from adult rats | Q48456105 | ||
Chimeric GABAA/glycine receptors: expression and barbiturate pharmacology. | Q51580747 | ||
Anesthetic potencies of secondary alcohol enantiomers. | Q51797640 | ||
Ontogeny of GABAA receptor subunit mRNAs in rat spinal cord and dorsal root ganglia. | Q52220991 | ||
Embryonic stem cells alone are able to support fetal development in the mouse. | Q52239769 | ||
Genes for epilepsy mapped in the mouse. | Q54290517 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | maternal health | Q6786626 |
cleft palate | Q3889390 | ||
Gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 | Q21981106 | ||
P304 | page(s) | 4143–4148 | |
P577 | publication date | 1997-04-15 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior | |
P478 | volume | 94 |
Q48474436 | A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity |
Q33759074 | A deficit of functional GABA(A) receptors in neurons of beta 3 subunit knockout mice |
Q36757273 | A model system to study genomic imprinting of human genes |
Q35601037 | A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and angelman syndromes |
Q48542489 | Activity-dependent ubiquitination of GABA(A) receptors regulates their accumulation at synaptic sites |
Q33732497 | Adenosine-to-inosine RNA editing affects trafficking of the gamma-aminobutyric acid type A (GABA(A)) receptor |
Q36937876 | Advances in behavioral genetics: mouse models of autism |
Q33787183 | Alcohol-induced motor impairment caused by increased extrasynaptic GABA(A) receptor activity |
Q21296802 | Alterations of GABAergic signaling in autism spectrum disorders |
Q35147300 | Altered GABA signaling in early life epilepsies |
Q35600442 | Altered GABAA receptor subunit expression and pharmacology in human Angelman syndrome cortex |
Q28590957 | Altered GABAA,slow inhibition and network oscillations in mice lacking the GABAA receptor beta3 subunit |
Q31878526 | Altered atypical coupling of gamma-aminobutyrate type A receptor agonist and convulsant binding sites in subunit-deficient mouse lines. |
Q43942885 | Altered receptor subtypes in the forebrain of GABA(A) receptor delta subunit-deficient mice: recruitment of gamma 2 subunits. |
Q27321157 | Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. |
Q56601749 | An update on GABAA receptors |
Q48494807 | Anaesthesia for Angelman syndrome |
Q33861522 | Anesthesia of a dental patient with Angelman syndrome -A case report-. |
Q34568411 | Animal models of restricted repetitive behavior in autism |
Q30469044 | Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders |
Q38335276 | Antisense inhibition of striatal GABAA receptor proteins decreases GABA-stimulated chloride uptake and increases cocaine sensitivity in rats |
Q34016353 | Are some idiopathic epilepsies disorders of ion channels?: A working hypothesis. |
Q34120956 | Association between a GABRB3 polymorphism and autism. |
Q46615044 | Association of the GABRB3 gene with nonsyndromic oral clefts |
Q35705869 | Autism as a disorder of neural information processing: directions for research and targets for therapy |
Q38981431 | Autism genetics - an overview |
Q35147366 | Autism: a "critical period" disorder? |
Q34521815 | Basic mechanisms of psychotropic drugs |
Q27025227 | Behavioral and Neuroanatomical Phenotypes in Mouse Models of Autism |
Q40410496 | Beyond Epilepsy and Autism: Disruption of GABRB3 Causes Ocular Hypopigmentation. |
Q40006933 | Bioelectric signalling via potassium channels: a mechanism for craniofacial dysmorphogenesis in KCNJ2-associated Andersen-Tawil Syndrome. |
Q47730991 | Brain regional heterogeneity of pH effects on GABA(A) receptor-associated [35s]TBPS binding |
Q50345135 | Case report: Angelman syndrome in an individual with a small SMC(15) and paternal uniparental disomy: a case report with reference to the assessment of cognitive functioning and autistic symptomatology |
Q80371617 | Characterization of chromosomal inversion of the mouse hairy ears (Eh) mutation associated with cleft palate |
Q36597021 | Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67 |
Q33545249 | Cleft palate is caused by CNS dysfunction in Gad1 and Viaat knockout mice |
Q26748761 | Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders |
Q50207596 | Clptm1 Limits Forward Trafficking of GABAA Receptors to Scale Inhibitory Synaptic Strength. |
Q28578301 | Colocalization of multiple GABA(A) receptor subtypes with gephyrin at postsynaptic sites |
Q55098524 | Common Ribs of Inhibitory Synaptic Dysfunction in the Umbrella of Neurodevelopmental Disorders. |
Q52118168 | Comparison of the expression patterns of two LIM-homeodomain genes, Lhx6 and L3/Lhx8, in the developing palate. |
Q36216409 | Consequences of the evolution of the GABA(A) receptor gene family |
Q44568826 | Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy |
Q36533812 | Cortical Tubers: Windows into Dysregulation of Epilepsy Risk and Synaptic Signaling Genes by MicroRNAs |
Q36298136 | Current models and future directions for understanding the neural circuitries of maternal behaviors in rodents |
Q62671564 | D2 dopamine receptor and GABAA receptor β3 subunit genes and alcoholism |
Q48382750 | Decreased expression of GABAA receptor alpha6 and beta3 subunits in stargazer mutant mice: a possible role for brain-derived neurotrophic factor in the regulation of cerebellar GABAA receptor expression? |
Q28263286 | Deficiency in protein L-isoaspartyl methyltransferase results in a fatal progressive epilepsy |
Q36131243 | Deleterious Rare Variants Reveal Risk for Loss of GABAA Receptor Function in Patients with Genetic Epilepsy and in the General Population |
Q38294267 | Disruption of GABA(A) receptors on GABAergic interneurons leads to increased oscillatory power in the olfactory bulb network |
Q36952307 | Disruption of the murine Ap2β1 gene causes nonsyndromic cleft palate |
Q52130756 | Distinct multi-joint control strategies in spastic diplegia associated with prematurity or Angelman syndrome. |
Q77892020 | Do we understand the evolution of genomic imprinting? |
Q34749269 | Drug interactions at GABA(A) receptors |
Q90369132 | Drug-selective Anesthetic Insensitivity of Zebrafish Lacking γ-Aminobutyric Acid Type A Receptor β3 Subunits |
Q24797140 | Dynamic expression of a glutamate decarboxylase gene in multiple non-neural tissues during mouse development |
Q43639928 | Effect of embryonic knock-down of GABAA receptors on the levels of monoamines and their metabolites in the CNS of the mouse |
Q49270387 | Embryonic exposure to ethanol increases the susceptibility of larval zebrafish to chemically induced seizures |
Q34710990 | Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer |
Q48560999 | Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. |
Q34099226 | Epilepsy genes: the link between molecular dysfunction and pathophysiology |
Q41720371 | Epilepsy genetics: an abundance of riches for biologists. |
Q37964799 | Epilepsy in four genetically determined syndromes of intellectual disability |
Q33744544 | Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase |
Q28115275 | Epileptic encephalopathy de novo GABRB mutations impair GABAA receptor function |
Q39264422 | Establishment of a molecular embryonic stem cell developmental toxicity assay |
Q92619192 | Ether Lipid Deficiency in Mice Produces a Complex Behavioral Phenotype Mimicking Aspects of Human Psychiatric Disorders |
Q26741939 | Excitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders |
Q46510840 | Excitatory GABA action is essential for morphological maturation of cortical neurons in vivo |
Q34592214 | From gene to behavior and back again: new perspectives on GABAA receptor subunit selectivity of alcohol actions |
Q28507175 | Functional role of GABAergic innervation of the cochlea: phenotypic analysis of mice lacking GABA(A) receptor subunits alpha 1, alpha 2, alpha 5, alpha 6, beta 2, beta 3, or delta. |
Q47109359 | GABA A Receptor Coupling Junction and Pore GABRB3 Mutations are Linked to Early-Onset Epileptic Encephalopathy |
Q33748759 | GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man. |
Q37115526 | GABA effects during neuronal differentiation of stem cells. |
Q43824668 | GABA influences the development of the ventromedial nucleus of the hypothalamus. |
Q42444397 | GABA neurotransmitter signaling in the developing mouse lens: dynamic regulation of components and functionality |
Q35138195 | GABA(A) Receptor β3 Subunit Expression Regulates Tonic Current in Developing Striatopallidal Medium Spiny Neurons |
Q73934483 | GABA(A) receptor beta(2) subunit mRNA content is differentially regulated in ethanol-dependent DBA/2J and C57BL/6J mice |
Q44274618 | GABA(A) receptor beta3 subunit deletion decreases alpha2/3 subunits and IPSC duration |
Q37229115 | GABA(A) receptor downregulation in brains of subjects with autism |
Q37965230 | GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam |
Q34204921 | GABA(A) receptor subtypes: dissecting their pharmacological functions |
Q47331104 | GABAA Receptor Subtype Mechanisms and the Abuse-Related Effects of Ethanol: Genetic and Pharmacological Evidence |
Q33789553 | GABAA receptor subunit gene polymorphisms predict symptom-based and developmental deficits in Chinese Han children and adolescents with autistic spectrum disorders |
Q34979365 | GABAA receptor trafficking-mediated plasticity of inhibitory synapses |
Q30481664 | GABAB receptors role in cell migration and positioning within the ventromedial nucleus of the hypothalamus. |
Q28589691 | GABAergic neurons regulate lateral ventricular development via transcription factor Pax5 |
Q36411551 | GABRB3 gene deficient mice: a potential model of autism spectrum disorder |
Q34707709 | GAD isoforms exhibit distinct spatiotemporal expression patterns in the developing mouse lens: correlation with Dlx2 and Dlx5. |
Q24657958 | Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder |
Q35846750 | Gabrb3 gene deficient mice exhibit increased risk assessment behavior, hypotonia and expansion of the plexus of locus coeruleus dendrites |
Q37730289 | Gamma-aminobutyric acid type A receptor β3 subunit forebrain-specific knockout mice are resistant to the amnestic effect of isoflurane. |
Q48708923 | Gene expression in the brain across the sleep-waking cycle |
Q34657339 | Gene/environment causes of cleft lip and/or palate |
Q24595524 | General anaesthetic actions on ligand-gated ion channels |
Q47967839 | Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy. |
Q44281916 | Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. |
Q33537117 | Genetic dissection of the molecular target(s) of anesthetics with the gene knockout approach in mice |
Q37098748 | Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome. |
Q36675876 | Genetic variability in glutamic acid decarboxylase genes: associations with post-traumatic seizures after severe TBI. |
Q35038945 | Higher seizure susceptibility and enhanced tyrosine phosphorylation of N-methyl-D-aspartate receptor subunit 2B in fyn transgenic mice |
Q24802555 | Homozygosity for a missense mutation in the 67 kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: parallels with Stiff-Person Syndrome and other movement disorders |
Q42523705 | Hypoplasia of spiral and Scarpa's ganglion cells in GABA(A) receptor beta(3) subunit knockout mice. |
Q24532789 | Identification of Four Highly Conserved Genes between Breakpoint Hotspots BP1 and BP2 of the Prader-Willi/Angelman Syndromes Deletion Region That Have Undergone Evolutionary Transposition Mediated by Flanking Duplicons |
Q48198075 | Identification of the sites for CaMK-II-dependent phosphorylation of GABA(A) receptors. |
Q28275427 | Immunologic and neurodevelopmental susceptibilities of autism |
Q36906435 | Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism |
Q47739224 | Imprinting in Angelman and Prader-Willi syndromes |
Q28204257 | Increased Expression of GABAAReceptor β-Subunits in the Hippocampus of Patients with Temporal Lobe Epilepsy |
Q48104116 | Increased acute cocaine sensitivity and decreased cocaine sensitization in GABA(A) receptor beta3 subunit knockout mice |
Q35160645 | Inhibitory synapse formation in a co-culture model incorporating GABAergic medium spiny neurons and HEK293 cells stably expressing GABAA receptors. |
Q36439772 | Insertional mutagenesis by a hybrid piggyBac and sleeping beauty transposon in the rat. |
Q50281746 | Insulin receptor sensitization restores neocortical excitation/inhibition balance in a mouse model of autism |
Q34247716 | Interneuron dysfunction in psychiatric disorders |
Q47269323 | Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies |
Q33534658 | Ion channels and the genetic contribution to epilepsy |
Q34810140 | Is there more to GABA than synaptic inhibition? |
Q36779166 | Isolated cleft palate in mice with a targeted mutation of the LIM homeobox gene lhx8 |
Q34464773 | Ketogenic diet, amino acid metabolism, and seizure control |
Q43436501 | Knockouts model the 100 best-selling drugs--will they model the next 100? |
Q28383456 | Letting a typical mouse judge whether mouse social interactions are atypical |
Q34385408 | Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers |
Q43594220 | Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice. |
Q33761809 | Low dose acute alcohol effects on GABA A receptor subtypes |
Q56909155 | Mapping of the gene for a novel spinocerebellar ataxia with pure cerebellar signs and epilepsy |
Q53932634 | Mapping quantitative trait loci for seizure response to a GABAA receptor inverse agonist in mice. |
Q36190572 | Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism |
Q34995058 | Mechanisms of GABAA receptor assembly and trafficking: implications for the modulation of inhibitory neurotransmission. |
Q46471442 | Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. |
Q44444573 | Microarray analysis of murine palatogenesis: Temporal expression of genes during normal palate development |
Q33912978 | Modulation of absence seizures by the GABA(A) receptor: a critical rolefor metabotropic glutamate receptor 4 (mGluR4). |
Q26795762 | Molecular basis of cleft palates in mice |
Q34572217 | Molecular bioelectricity: how endogenous voltage potentials control cell behavior and instruct pattern regulation in vivo |
Q36581780 | Molecular control of secondary palate development |
Q49467906 | Mom Genes: A Role for Loss of Maternal Ube3a in GABAergic Neurons in Angelman Syndrome |
Q35006507 | Mouse models for psychiatric disorders. |
Q44388405 | Mouse models of Angelman syndrome, a neurodevelopmental disorder, display different brain regional GABA(A) receptor alterations |
Q79249829 | Mutation screen of the gene encoding GABRB3 in Chinese patients with childhood absence epilepsy |
Q33912426 | Mutations affecting GABAergic signaling in seizures and epilepsy |
Q37716303 | Mutations in GABAA receptor subunits associated with genetic epilepsies |
Q33941556 | Neurological diseases caused by ion-channel mutations |
Q33302208 | New insight into the role of the beta3 subunit of the GABAA-R in development, behavior, body weight regulation, and anesthesia revealed by conditional gene knockout |
Q33833572 | New insights into the mechanism of action of hypnotics |
Q34222312 | New thoughts on female precocious puberty |
Q33894536 | Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function |
Q73048456 | Nonneuronal expression of the GABA(A) beta3 subunit gene is required for normal palate development in mice |
Q33808930 | Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the gamma2 subunit of the gamma-aminobutyrate type A receptor. |
Q48087748 | Olfactory bulb gamma oscillations are enhanced with task demands |
Q38634066 | Oxytocin and Animal Models for Autism Spectrum Disorder. |
Q42602275 | Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines |
Q46879489 | Pharmacologic evidence for abnormal thalamocortical functioning in GABA receptor beta3 subunit-deficient mice, a model of Angelman syndrome |
Q52596297 | Planarian Regeneration as a Model of Anatomical Homeostasis: Recent Progress in Biophysical and Computational Approaches. |
Q42772124 | Positive feedback regulation between gamma-aminobutyric acid type A (GABA(A)) receptor signaling and brain-derived neurotrophic factor (BDNF) release in developing neurons |
Q57066913 | Possible association between childhood absence epilepsy and the gene encoding GABRB3 |
Q38085546 | Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management |
Q48240102 | Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin |
Q50100140 | Prader-Willi Syndrome and Angelman Syndrome: Visualisation of the molecular pathways for two chromosomal disorders. |
Q30366940 | Prioritizing the development of mouse models for childhood brain disorders |
Q35806141 | Quantitative localisation of synaptic and extrasynaptic GABAA receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabelling. |
Q91838609 | RDH10 function is necessary for spontaneous fetal mouth movement that facilitates palate shelf elevation |
Q34561466 | Rearing in enriched environment increases parvalbumin-positive small neurons in the amygdala and decreases anxiety-like behavior of male rats |
Q33755692 | Recent advances in the genetics of epilepsy: insights from human and animal studies |
Q41720980 | Reciprocal inhibitory connections regulate the spatiotemporal properties of intrathalamic oscillations. |
Q30486124 | Reduced conditioned fear response in mice that lack Dlx1 and show subtype-specific loss of interneurons |
Q35187772 | Reducing GABA receptors |
Q50066465 | Regulation of synapse development by Vgat deletion from ErbB4-positive interneurons. |
Q35586893 | Retinoic acid, GABA-ergic, and TGF-beta signaling systems are involved in human cleft palate fibroblast phenotype |
Q34499035 | Rett syndrome: a Rosetta stone for understanding the molecular pathogenesis of autism |
Q33770162 | Role of GABA receptors in fetal lung development in rats |
Q44588647 | Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. |
Q52538742 | Seizures and neuronal damage in mice lacking vesicular zinc. |
Q51418961 | Sensory thresholds and the antinociceptive effects of GABA receptor agonists in mice lacking the beta3 subunit of the GABA(A) receptor. |
Q40467316 | Similarities in Mechanisms and Treatments for Epileptic and Nonepileptic Myoclonus. |
Q44207392 | Sleep states and sleep electroencephalographic spectral power in mice lacking the beta 3 subunit of the GABA(A) receptor |
Q30468708 | Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3. |
Q24682020 | Sox6 is a candidate gene for p100H myopathy, heart block, and sudden neonatal death |
Q53038576 | Spectrum of epilepsy and electroencephalogram patterns in idic (15) syndrome. |
Q30401824 | Stem cells and modeling of autism spectrum disorders |
Q30498571 | Stress-hyperresponsive WKY rats demonstrate depressed dorsal raphe neuronal excitability and dysregulated CRF-mediated responses |
Q82214620 | Studies of gamma-aminobutyric acid type A receptor beta3 (GABRB3) and glutamic acid decarboxylase 67 (GAD67) with oral clefts |
Q33969791 | Synaptic GABAA receptor clustering without the γ2 subunit |
Q34606705 | Synaptic competition sculpts the development of GABAergic axo-dendritic but not perisomatic synapses |
Q38295906 | Synaptic localization of neurotransmitter receptors: comparing mechanisms for AMPA and GABAA receptors |
Q39018797 | Tapping the Brakes: Cellular and Synaptic Mechanisms that Regulate Thalamic Oscillations |
Q28507614 | Targeted disruption of the GABA(A) receptor delta subunit gene leads to an up-regulation of gamma 2 subunit-containing receptors in cerebellar granule cells |
Q47560551 | Tenuous Inhibitory GABAergic Signaling in the Reticular Thalamus |
Q39170149 | The building of the neocortex with non-hyperpolarizing neurotransmitters. |
Q24594577 | The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13 |
Q38579867 | The complex genetics in autism spectrum disorders |
Q37383066 | The etiopathogenesis of cleft lip and cleft palate: usefulness and caveats of mouse models |
Q34138977 | The human gamma-aminobutyric acid A receptor delta (GABRD) gene: molecular characterisation and tissue-specific expression |
Q37541565 | The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type. |
Q36795785 | The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect |
Q41017868 | The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit. |
Q35680716 | The neurobiology of mouse models syntenic to human chromosome 15q. |
Q42729995 | The pathophysiology of restricted repetitive behavior |
Q34503835 | The physiological roles of vesicular GABA transporter during embryonic development: a study using knockout mice |
Q51378824 | Time-course effects of a single administration of cocaine on receptor binding and subunit mRNAs of GABA(A) receptors. |
Q58574000 | Toward the Language Oscillogenome |
Q51434692 | Towards better benzodiazepines. |
Q43744134 | Transgenic and knockout databases: behavioral profiles of mouse mutants |
Q28394524 | Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics |
Q48555641 | Two species of gamma oscillations in the olfactory bulb: dependence on behavioral state and synaptic interactions |
Q43780942 | Unexpected absence of correlation between the genetic mechanisms regulating beta-carboline-induced seizures and anxiety manifested in an elevated plus-maze test |
Q34829294 | Use of antiepileptic drugs for hyperkinetic movement disorders |
Q28392778 | Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions |
Q49924776 | Vagal nerve stimulation for medically refractory epilepsy in Angelman syndrome: a series of three cases |
Q81546504 | [The GABA(A) receptor family: possibilities for the development of better anesthetics] |
Q37065672 | γ-Aminobutyric Acid Type A (GABAA) Receptor Subunits Play a Direct Structural Role in Synaptic Contact Formation via Their N-terminal Extracellular Domains. |
Search more.